Snapshot
In this protocol, Dr, Sibai reviews the pathophysiology, diagnosis, and management of preeclampsia. Included are algorithms for management of mild hypertension-preeclampsia and severe preeclampsia.
As the author notes, women who develop preeclampsia in their first pregnancy are at increased risk (20%) for development of preeclampsia in subsequent pregnancies. With severe disease in a first pregnancy, the risk of recurrence is about 30%. With severe disease presenting in the second trimester, the risk of recurrent preeclampsia is 50%. There is an increased risk of chronic hypertension and undiagnosed renal disease, especially in patients with two episodes of severe preeclampsia in the second trimester. These patients should have adequate medical evaluation postpartum. There is also increased risk of intrauterine growth restriction in a subsequent pregnancy.
KEY MESSAGES:
Baha M. Sibai, MD University of Cincinnati College of Medicine, Ohio
Single iron infusion in late pregnancy significantly reduces anemia risk
January 22nd 2025A recent study found that a single dose of intravenous iron in the third trimester is superior to oral iron in reducing anemia rates in pregnant women, ensuring better outcomes for mother and baby.
Read More
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
Published: January 22nd 2025 | Updated: January 22nd 2025The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.
Read More
